Document is current
Any future updates will be listed below
-
Authors
Avila, Monica
Grinsfelder, Michaela Onstad
Pham, Melissa
Westin, Shannon N. https://orcid.org/0000-0002-1922-0156
-
Funding
Funding for this research was provided by:
National Cancer Institute (5P50CA098258-13)
National Institutes of Health (5 T32 CA101642 02)
GOG Foundation (Scholar Investigator)
- License Information
-
More Information
Article History
Accepted: 5 July 2022
First Online: 19 November 2022
Declarations
:
: Monica Avila declares that she has no conflict of interest. Michaela Onstad Grinsfelder declares that she has no conflict of interest. Melissa Pham declares that she has no conflict of interest.Shannon N. Westin has received research funding from AstraZeneca, Novartis, Bayer, OncXerna, Clovis Oncology, Roche/Genentech, Cotinga Pharmaceuticals, Zentalis, GSK, Bio-Path, Mereo, and AvengeBio.Shannon N. Westin has received consulting fees from Agenus, AstraZeneca, EQRX, GSK, Clovis Oncology, ImmunoGen, Eisai, Lilly, Merck, Zentalis, Mereo, Roche/Genentech, Mersana, Caris, SeaGen, Vincerx, Nuvectis and NGM Bio.
